Literature DB >> 30891338

In vivo monitoring and high-resolution characterizing of the prednisolone-induced osteoporotic process on adult zebrafish by optical coherence tomography.

Yanping Lin1, Xiang Xiang1, Tingru Chen1, Chudan Gao1, Hongbo Fu1, Limei Wang2, Lijun Deng3, Lvming Zeng3,4, Jian Zhang1.   

Abstract

Because of its similar genetic makeup with humans, zebrafish are an available and well-established osteoporosis model in vivo for anti-osteoporosis drug development as well as the drug safety-evaluation process. However, few optical imaging methods could effectively visualize the bone of adult zebrafish due to their limited penetration depth. In this paper, in vivo high-resolution and long-term characterization of a prednisolone-induced osteoporotic zebrafish model was achieved with spectral-domain optical coherence tomography (SD-OCT). The capability of three-dimensional SD-OCT imaging was also demonstrated in this study. With SD-OCT images, we could non-destructively monitor the deforming process of adult zebrafish skull from several directions at any time. There is good correlation and agreement between SD-OCT and histology. Valuable phenomenon such as bone defects could be quantitatively evaluated using the SD-OCT images at different time points during a period of 21 days.

Entities:  

Year:  2019        PMID: 30891338      PMCID: PMC6420289          DOI: 10.1364/BOE.10.001184

Source DB:  PubMed          Journal:  Biomed Opt Express        ISSN: 2156-7085            Impact factor:   3.732


  2 in total

1.  Optical coherence tomography characterizes the roughness and thickness of the heterogeneous layer on cortical bone surface induced by Er:YAG laser ablation at different moisture contents.

Authors:  Wenyan Huang; Chudan Gao; Yintao Lan; Sujuan Zeng; Janak L Pathak; Miao Zhou; Lihong Ge; Jian Zhang
Journal:  Quant Imaging Med Surg       Date:  2020-03

Review 2.  Zebrafish Models of Human Skeletal Disorders: Embryo and Adult Swimming Together.

Authors:  Marta Carnovali; Giuseppe Banfi; Massimo Mariotti
Journal:  Biomed Res Int       Date:  2019-11-20       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.